60
Views
3
CrossRef citations to date
0
Altmetric
Case Report

Consecutive successful pregnancies subsequent to intravenous immunoglobulin therapy in a patient with recurrent spontaneous miscarriage

, , , , &
Pages 337-344 | Published online: 11 Dec 2015

References

  • StephensonMDKuttehWHPurkissSIntravenous immunoglobulin and idiopathic secondary recurrent miscarriage: a multi-centered randomized placebo-controlled trialHum Reprod2010252203220920634190
  • DayaSGunbyJPorterFScottJClarkDACritical analysis of intravenous immunoglobulin therapy for recurrent miscarriageHum Reprod Update1999547548210582784
  • AtaBTanSLShehataFHozlerHBuckettWA systematic review of intravenous immunoglobulin for treatment of unexplained recurrent miscarriageFertil Steril2011951080108521232738
  • ReaganLA prospective study of spontaneous abortionBeardRWSharpFEarly Pregnancy Loss: Mechanisms of TreatmentLondonSpringer-Verlag19882327
  • WilcoxAJWeinbergCRO’ConnorJFIncidence of early loss of pregnancyN Engl J Med19883191891943393170
  • AlbermanEThe epidemiology of repeated abortionsBeardRWSharpFEarly Pregnancy Loss: Mechanisms of TreatmentLondonSpringer-Verlag1988917
  • ChristiansenOBPedersonBRosgaardAHusthMA randomized; double-blind, placebo-controlled trial of intravenous immunoglobulin in the prevention of recurrent miscarriage: evidence of a therapeutic effect in women with secondary recurrent miscarriageHum Reprod20021780981611870141
  • RaiRReaganLRecurrent miscarriageLancet200636860161116905025
  • DiejomaohMFRecurrent spontaneous miscarriage is still a challenging, diagnostic and therapeutic quagmireMed Princ Pract201524Suppl I385525428171
  • The practice committee of the American Society for Reproductive medicineEvaluation and treatment of recurrent pregnancy loss. A committee opinionFertil Steril2012981103111122835448
  • JaslowCRCarneyJLKuttehWHDiagnostic factors identified in 1020 women with two versus three or more recurrent pregnancy lossesFertil Steril2010931234124319338986
  • BrezinaPRKuttehWHClassic and cutting-edge strategies for the management of early pregnancy lossObst Gynecol Clin North Am2014411824491981
  • ShapiraERatzonRShoham-VardiISerjienkoRMazorMBashiriAPrimary versus secondary recurrent pregnancy loss-epidemiological characteristics, etiology, and next pregnancy outcomeJ Perinat Med20124038939622752770
  • DiejomaohMFAl-AzemiMJirousJThe aetiology and pattern of recurrent pregnancy lossJ Obstet Gynaecol200222626712521732
  • PorterTFLa CoursiereYScottJRImmunotherapy for recurrent miscarriageCochrane Database Syst Rev20062CD00011216625529
  • QuenbySBatesMDoigTPre-implantation endometrial leukocytes in women with recurrent miscarriageHum Reprod1999142386239110469717
  • KingKSmithSChapmanMSacksGDetailed analysis of peripheral blood natural killer [NK] cells in women with recurrent miscarriageHum Reprod201025525819819893
  • ChristiansenOBLarsenECEgerupPLunoeeLEgestadLNielsenHSIntravenous immunoglobulin treatment for secondary recurrent miscarriage: a randomised, double-blind, placebo-controlled trialBJOG201512250050825412569
  • CliffordKFlanaganAMReaganLEndometrial CD56+ natural killer cells in women with recurrent miscarriage: a histomorphometric studyHum Reprod1999142727273010548610
  • Ramos-MedinaRGarcía-SegoviaAGilJExperience in IVIg therapy for selected women with recurrent reproductive failure and NK cell expansionAm J Reprod Immunol20147145846624612159
  • AokiKKajiuraSMatsumotoYPreconceptional natural killer – cell activity as a predictor of miscarriageLancet1995345134013427752757
  • YamadaHMorikawaMKatoEHShimadaSKobashiGMinakamiHPre-conceptional natural killer cell activity and percentage as predictors of biochemical pregnancy and spontaneous abortion with normal chromosome karyotypeAm J Reprod Immuol200350351354
  • PerriconeRDi MuzioGPerriconeCHigh levels of peripheral blood NK cells in women suffering from recurrent spontaneous abortion are reverted from high-dose intravenous immunoglobulinAm J Reprod Immunol20065523223916451358
  • SilverRMIntravenous immune globulin: another disappointing treatment for pregnancy lossBJOG201512250925600311
  • ChristiansenOBMathiesenOHusthMPlacebo-controlled trial of treatment of unexplained secondary recurrent spontaneous abortions with IV. ImmunoglobulinHum Reprod199519269026958567794
  • StephensonMDDreherKHonlihanEWuVPrevention of unexplained recurrent spontaneous abortion using intravenous immunoglobulin: a prospective, randomized, double blinded, placebo-controlled trialAm J Reprod Immunol19983982889506206
  • JablonowskaBSelbingAPalfiMErnerudhJKjellbergSLindtonBPrevention of recurrent spontaneous abortion by intravenous immunoglobulin: a double-blind placebo-controlled studyHum Reprod19991483884110221723
  • CoulamCBAcacioBDoes immunotherapy for treatment of reproductive failure enhance live births?Am J Reprod Immunol20126729630322340745
  • HuttonBSharmaRFergussonDUse of intravenous immunoglobulin for recurrent spontaneous miscarriage: a systemic reviewBJOG200711413414217166218
  • MarquardKWestphalLMMilkiAALathiRBEtiology of recurrent pregnancy loss in women over the age of 35 yearsFertil Steril2010941473147719643401
  • MoraruMCarboneJAlecsandruDIntravenous immunoglobulin treatment increased live birth rate in a Spanish cohort of women with recurrent reproductive failure and expended CD 56+ cellsAm J Reprod Immunol201268758422509929
  • GlueckCJWangPGoldenbergNSieve-SmithLPregnancy outcomes among women with polycystic ovary syndrome treated with metforminHum Reprod2002172858286412407039
  • Szekeres-BarthoJImmunologic relationship between the mother and fetusIntern Rev Immunol200221471496
  • RaghupathyRAl MutawaEMakhseedMAziziehFSzekeres-BarthoJModulation of cytokine production by dydrogesterone in lymphocytes from women with recurrent miscarriageBJOG20051121096110116045524
  • KumarABegumNPrasadSAggarwalSSharmaSOral dydrogesterone treatment during early pregnancy to prevent recurrent pregnancy loss and its role in modulation of cytokine production: a double-blind, randomized, parallel, placebo-controlled trialFertil Steril20141021357136325241364
  • LeongHStachnikJBonkMEMatuszewskiMSUnlabeled uses of intravenous immunoglobulinAm J Health Syst Pharm2008651815182418796422